SMI Expanded
1.717,62
PKT
+22,26
PKT
+1,31
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.04.05 | Novartis Hold | SEB | |
| 27.04.05 | Novartis Kaufen | NATIONAL-BANK | |
| 21.04.05 | Geberit Buy | Sarasin Research | |
| 21.04.05 | Roche Sector Outperform | Vontobel | |
| 21.04.05 | Kühne + Nagel International Neutral | Sarasin Research | |
| 22.04.05 | Novartis Kaufen | Helaba Trust | |
| 21.04.05 | Roche Outperform | Goldman Sachs | |
| 21.04.05 | Novartis Buy | Merrill Lynch | |
| 25.04.05 | Lindt Neutral | Sarasin Research | |
| 21.04.05 | Novartis Akkumulieren | Independent Research | |
| 21.04.05 | Nestlé Neutral | Sarasin Research | |
| 21.04.05 | Novartis Neutral | Sarasin Research | |
| 20.04.05 | Roche Buy | Sarasin Research | |
| 20.04.05 | Nestlé In-Line | Goldman Sachs | |
| 20.04.05 | Roche Outperform | Goldman Sachs | |
| 20.04.05 | Nestlé Overweight | JP Morgan | |
| 20.04.05 | Roche Overweight | JP Morgan | |
| 20.04.05 | Nestlé Kaufen | Helaba Trust | |
| 20.04.05 | Roche Equal weight | Lehman Brothers | |
| 20.04.05 | Logitech In-Line | Goldman Sachs | |
| 20.04.05 | ABB (Asea Brown Boveri) Kaufen | Helaba Trust | |
| 21.04.05 | Logitech Neutral | Sarasin Research | |
| 19.04.05 | Novartis Buy | Merrill Lynch | |
| 19.04.05 | Roche Akkumulieren | Independent Research | |
| 19.04.05 | ABB (Asea Brown Boveri) Overweight | JP Morgan | |
| 21.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 19.04.05 | Roche Buy | Sarasin Research | |
| 25.04.05 | Baloise Neutral | Sal. Oppenheim | |
| 19.04.05 | Roche Halten | Helaba Trust | |
| 19.04.05 | Novartis Neutral | JP Morgan | |
| 18.04.05 | Baloise Accumulate | Helvea | |
| 19.04.05 | Roche Overweight | JP Morgan | |
| 18.04.05 | Novartis Outperform | Goldman Sachs | |
| 18.04.05 | Baloise Sector Outperform | Vontobel | |
| 19.04.05 | Roche Equal weight | Lehman Brothers | |
| 19.04.05 | Clariant Neutral | HypoVereinsbank | |
| 18.04.05 | UBS Market Perform | Vontobel | |
| 18.04.05 | UBS Market Outperform | Vontobel | |
| 18.04.05 | Swiss Prime Site Neutral | Sarasin Research | |
| 18.04.05 | Novartis Neutral | HypoVereinsbank |